Cart
sales@molnova.com
Vanillyl butyl ether
CAS No. 82654-98-6
Vanillyl butyl ether( —— )
Catalog No. M19151 CAS No. 82654-98-6
Vanillyl butyl ether (VBE)is a capsaicin analogue,induce sensory irritation in humans,Vanillyl butyl ether is an alkoxy-substituted benzyl derivative mainly used as a flavoring agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 26 | In Stock |
|
Biological Information
-
Product NameVanillyl butyl ether
-
NoteResearch use only, not for human use.
-
Brief DescriptionVanillyl butyl ether (VBE)is a capsaicin analogue,induce sensory irritation in humans,Vanillyl butyl ether is an alkoxy-substituted benzyl derivative mainly used as a flavoring agent.
-
DescriptionVanillyl butyl ether (VBE)is a capsaicin analogue,induce sensory irritation in humans,Vanillyl butyl ether is an alkoxy-substituted benzyl derivative mainly used as a flavoring agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82654-98-6
-
Formula Weight210.27
-
Molecular FormulaC12H18O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (475.58 mM)
-
SMILESCCCCOCC1=CC=C(O)C(OC)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Takaishi M,etal.Reciprocal effects of capsaicin and menthol on thermosensation through regulated activities of TRPV1 and TRPM8.J Physiol Sci. 2016 Mar;66(2):143-55.
molnova catalog
related products
-
Aurantiamide
Aurantiamide has anti-cancer anti-inflammatory and antinociceptive activities it may suppress the growth of malignant gliomas by blocking autophagic flux.Aurantiamide has an anti-neuroinflammatory effect on LPS stimulation through its inhibition of the NF-κB JNK and p38 pathways.
-
Scopolin
Scopolin can reduce the clinical symptoms of rat AIA by inhibiting inflammation and angiogenesis, and this compound may be a potent agent for angiogenesis related diseases and can serve as a structural base for screening more potent synthetic analogs.
-
DRI-C21045
Dri-c21045 showed concentration-dependent inhibition of NF-kB activation and all CD40L induced by B cell proliferation with IC50 of 17.1 μM and 4.5 μM.
